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Although low molecular weight (LMW) dextran has been said to decrease the lethality of experimental 
acute pancreatitis (AP) by reversing stasis in the pancreatic microcirculation, the actual mechanism(s) 
of action is unknown. This investigation was designed to measure the effects of low molecular weight 
dextran on pancreatic capillary flow (Q,--r) and arteriovenous shunt flow (QAvs), and on pancreatic 
oxygen consumption (Or&) following bile-trypsin-induced AP in dogs. Total pancreatic blood flow 
(QT) was measured with an electromagnetic flow probe on the superior pancreaticoduodenal artery 
(SPDA). QAvs was measured by liver trapping of 99mTc-aIbumin microspheres after SPDA injection. 
Qc-r was calculated as QT minus QAvs. Seventeen dogs were treated with lactated Ringer’s (LR) solution 
at 6.5 ml/kg/hr; 10 dogs were treated with LMW dextran 10% in normal saline at 1.5 ml/kg/hr plus 
LR at 5.0 ml/kg/hr. Mean arterial and central venous pressures remained constant throughout the 4- 
hr experiment. In the dogs receiving LR only, Qr decreased from 42.7 to 24.4 ml/min (P < 0.001); 
QAvs remained constant at 1.35 f 0.04 ml/mitt. During the first 30 min O,C, decreased from 1.17 to 
0.76 ml Oz/min (P < 0.05) and remained constant thereafter. LMW dextran treatment altered none 
of these hemodynamic or metabolic parameters significantly. Conclusions: bile trypsin AP in the dog 
causes significant decreases in Qr and QcAp without altering QAvs . The decrease in O&. in association 
with a constant Q*vs suggests a metabolic block to oxygen uptake at the cellular level. Continuous 
infusion of LMW dextran at a dose of 1.5 ml/kg/hr in the dog does not reverse these abnormalities. 
INTRODUCTION 
Since Panum showed in 1862 that acute 
pancreatitis could be produced by injection 
of wax droplets into the pancreatic arterial 
circulation, it has been recognized that vas- 
cular damage may play a role in acute pan- 
creatitis [22]. Increasingly, there has been em- 
phasis on the interplay of the “vascular fac- 
tors” in the pathological progression of simple 
edematous pancreatitis to frank parenchymal 
necrosis. Studies of pancreatic histopathology 
after pancreatitis have shown damage to blood 
vessel walls, the presence of venous thrombi 
[28], and poor filling of vessels in intralobular 
areas [29]. Severe constriction of pancreatic 
arteries and: arterioles as well as an increase 
in the size and number of arteriovenous shunts 
and severe venous stasis have also been ob- 
served [24]. 
Clinically it was recognized that severe fluid 
volume deficits were characteristic of acute 
hemorrhagic pancreatitis and that vigorous 
fluid replacement improved survival [ lo]. 
Dextrans were first evaluated as therapeutic 
agents in acute pancreatitis because of their 
ability to expand intravascular volume, but 
initial trials were disappointing [2, 191. How- 
ever, subsequent experimental studies were 
more encouraging. Animals treated with low 
molecular weight (LMW) dextran showed im- 
proved survival compared to those treated with 
albumin or crystalloid solutions [7, 321. In 
addition, evidence accumulated that pan- 
creatic blood flow was maintained in animals 
with hemorrhagic pancreatitis with the use of 
LMW dextran [6, 8, 151. In contrast, saline- 
treated animals demonstrated markedly de- 
creased pancreatic blood flow. Moreover, in 
certain types of experimental pancreatitis, 
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LMW dextran has also been shown to have 
salutary effects on pancreatic oxygen con- 
sumption [9], 
Work by Donaldson and Schenk suggested 
increased intrapancreatic arteriovenous (AV) 
shunting as the etiology of the decreased pan- 
creatic oxygen consumption seen with acute 
pancreatitis [9]. Increased AV shunting in 
acute pancreatitis has never been docu- 
mented, and the effect of LMW dextran on 
such shunts is not known. This study was un- 
dertaken (1) to investigate the changes in pan- 
creatic blood flow distribution between the 
capillary circulation and through arteriove- 
nous shunts; (2) to determine whether the ob- 
served decreases in pancreatic oxygen con- 
sumption occur primarily from increased ar- 
teriovenous shunt flow; and (3) to determine 
the influence of LMW dextran on both the 
distribution of pancreatic blood flow and on 
pancreatic oxygen consumption. 
MATERIALS AND METHODS 
Twenty-seven conditioned mongrel dogs of 
both sexes, weighing 20.9 to 47.7 kg, were 
fasted for 20 hr, anesthetized with intrave- 
nous thiopental sodium (30 mg/kg), intu- 
bated, and ventilated with room air using a 
Harvard ventilator. Anesthesia was main- 
tained with intermittent supplemental doses 
of Pentothal sodium. Respiratory activity was 
adjusted to maintain a slight hypocarbia and 
a normal pOZ. The animal’s core temperature 
was maintained at 38 it_ 0S”C with a heating 
mattress and heat lamps. The left internal jug- 
ular vein was cannulated for fluid adminis- 
tration and central venous pressure monitor- 
ing. The right internal jugular vein was can- 
nulated with a Swan-Ganz catheter for 
thermodilution cardiac output studies and for 
mixed venous blood sampling. The right ca- 
rotid artery was cannulated for pressure mon- 
itoring and arterial blood sampling. 
Preliminary studies in our laboratory have 
confirmed the compartmental nature of the 
arterial blood supply to the canine pancreas. 
The superior pancreaticoduodenal artery sup- 
plies the head, neck, and most of the uncinate 
process, the splenic artery provides branches 
supplying the body and tail, and the inferior 
pancreaticoduodenal artery supplies the distal 
tip of the uncinate process. A method com- 
monly used to measure pancreatic blood flow 
employs an electromagnetic flow probe placed 
around the gastroduodenal artery after liga- 
tion of the right gastroepiploic artery, the pan- 
creatic branches of the splenic artery, and the 
inferior pancreaticoduodenal artery [8]. How- 
ever, we have documented significantly de- 
creased perfusion of the body and tail when 
the splenic artery branches to the pancreas are 
ligated. To measure blood flow through a sin- 
gle inflow vessel and to exclude changes which 
might result from hypoperfusion of a segment 
of the pancreas, our model included ligation 
of the pancreas at the neck and excision of 
the body and tail, with recording of the weight 
of the excised segment (Fig. 1). The inferior 
pancreaticoduodenal artery was ligated with 
preservation of its accompanying vein. Para- 
duodenal collaterals running along the distal 
duodenum were also ligated. The right gas- 
troepiploic artery was ligated distally and can- 
nulated proximally, with the tip of the can- 
nula positioned at the junction with the gas- 
troduodenal artery. To obtain pancreatic 
effluent blood for oxygen analysis, the supe- 
rior pancreaticoduodenal vein was cannu- 
lated at a point distal to its pancreatic tribu- 
taries, and the tip of the cannula was posi- 
tioned at a point proximal to all pancreatic 
tributaries, but short of its junction with the 
portal vein. The major pancreatic duct was 
cannulated external to the duodenum. The 
duct from the uncinate process was cannu- 
lated either at its bifurcation with the major 
duct or at the level of the accessory duct. When 
not cannulated, the accessory duct was li- 
gated. An electromagnetic flow probe was 
placed around the gastroduodenal artery dis- 
tal to the last hepatic artery branch and an 
encircling snare was placed on the gastroduo- 
denal artery proximal to the flow probe for 
purposes of intermittent occlusion. 
Following the surgical procedure, the ani- 
mals were allowed to stabilize for 30 min. Two 
sets of baseline measurements were then re- 
KNOL ET AL.: LOW MW DEXTRAN IN EXPERIMENTAL PANCREATITIS 75 
FIG. 1. Pancreatitis model: the body and tail of the pancreas have been excised, the right gastroepiploic 
artery (5) has been cannulated, and the inferior pancreaticcduodenal artery (6) has been ligated. Inset: The 
superior pancreaticoduodenal vein (9) and the pancreatic ducts (8) have been cannulated. The venous 
cannula has been placed with its tip just short of the portal vein (I 0). 
corded at 30-min intervals. Pancreatitis was 
induced by high pressure injection (140 mm 
Hg) of a solution of sterile autogenous bile (1 
ml/kg) containing crystalline trypsin (2000 U/ 
ml bile) [21]. 
Arteriovenous shunting across the pancreas 
was estimated by measurement of liver trap- 
ping of 15- 25-pm 99mTc-labeled albumin mi- 
crospheres (3M) injected into the pancreatic 
arterial circulation via the right gastroepiploic 
artery cannula. During injection, the snare on 
the gastroduodenal artery was tightened to 
prevent retrograde flow of microspheres into 
the hepatic arteries. Liver trapping of micro- 
spheres was measured by a gamma probe di- 
rected transversely at the right lobe of the liver 
through the right chest wall, using a lead shield 
to exclude activity from the pancreas. Stan- 
dardization was obtained at the termination 
of the experiment by injection of two doses 
of labeled microspheres directly into the por- 
tal vein via the superior pancreaticoduodenal 
venous catheter. The proportion of each in- 
jected dose passing through the pancreas to 
the liver was taken as a measure of percent 
AV shunting. 
One group (LR) of 17 dogs received lac- 
tated Ringer’s solution at 6.5 ml/kg/hr. Five 
dogs were observed for 3 hr and 12 dogs were 
observed for 4 hr. A second group (DEX) of 
10 dogs received LMW dextran (Rheoma- 
crodex), 10% solution in normal saline, at 1.5 
ml/kg/hr, supplemented by lactated Ringer’s 
solution at 5.0 ml/kg/hr. The dextran infu- 
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sion was begun with the induction of pancre- 
atitis. In the DEX group one dog was ob- 
served for 3 hr and 9 dogs were observed for 
4 hr. Measurements were taken at 30-min in- 
tervals. At the termination of the experiment 
the animals were sacrificed, the remaining 
pancreas was excised and weighed, and sam- 
ples were prepared for histologic evaluation. 
Statistical analysis utilized Student’s t test 
for parametric data and the median test for 
nonparametric data. Analysis was based both 
on changes from initial, using each dog as its 
own control, and on absolute values. Vari- 
ance is expressed as standard error of the 
mean. 
RESULTS 
Hemorrhagic pancreatitis developed in all 
animals. Observed changes in gross mor- 
phology included difise hemorrhage into and 
around the gland, saponification of surround- 
ing fat, and accumulation of significant 
amounts of hemorrhagic fluid within the ab- 
dominal cavity. In preliminary studies, this 
appearance correlated closely with the histo- 
logic picture of early necrotizing pancreatitis. 
Systemically, few alterations were ob- 
SeNed. Arterial pressure and central venous 
pressure did not vary significantly from base- 
line, and there were no significant differences 
between the experimental and control groups 
of animals (Fig. 2). Cardiac index was de- 
creased in both groups of dogs (Fig. 2). The 
LR dogs showed decreases that were signifi- 
cant (P < 0.05) at all time points beyond 60 
min, with a maximal decrease of 22% from a 
baseline value of 2.79 t- 0.18 to 2.17 + 0.18 
liters/min-m2 at 3 hr. By comparison, the 
DEX dogs showed a lesser maximal decrease 
(12%) from 2.89 + 0.19 to 2.50 + 0.13 liters/ 
min-m2, not a statistically significant de- 
crease. Differences in cardiac index between 
the groups were not statistically significant. 
Systemic oxygen extraction, when correlated 
with time, increased significantly in both 
groups (P < 0.05) over the 4 hr of the exper- 
iment, but there were no consistent significant 
intergroup differences (Fig. 3). 
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FIG. 2. Alterations in systemic blood pressure (BP), cardiac index (CI), and central venous pressure (CVP) 
following induction of pancreatitis. 
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FIG. 3. Systemic oxygen extraction following induction of pancreatitis. 
pancreatic arterial blood flow decreased in the 
LR dogs from a baseline value of 42.7 f 3.3 
ml/min to 33.9 k 2.7 ml/min at 60 min, and 
continued to decline to 24.9 f 1 i7 ml/min at 
3 hr (Fig. 4). The maximal decrease in pan- 
creatic blood flow (43%) to 24.4 f 2.2 ml/ 
min occurred at 4 hr. DEX dogs showed a 
similar maximal decrease (42%) from 62.7 
k 6.5 ml/min at baseline to 36.3 + 5.3 ml/ 
min at 3.5 hr. Although there appeared to be 
significant intergroup differences in pan- 
creatic blood flow, those differences were 
present prior to the induction of pancreatitis. 
Comparison of the groups using each animal 
as its own control demonstrated no significant 
differences in the relative decreases in flow 
between the groups (Fig. 5). Comparison of 
changes in pancreatic blood flow relative to 
systemic blood flow (pancreatic flow/cardiac 
output) showed a decline in both groups, but 
the observed changes were not significant (Fig. 
5). Arteriovenous shunt flow remained nearly 
constant between 1 and 2 ml/min throughout 
the experimental period, and no intergroup 
differences were observed (Fig. 4). 
Pancreatic oxygen consumption decreased 
within 30 min after induction of pancreatitis 
from 1.17 + 0.14 to 0.76 f 0.11 ml Oz/min 
(P < 0.05) in the LR group, and from 1.60 
f 0.15 to 0.73 + 0.Q9 ml 02/min (P < 0.01) 
in the DEX group (Fig. 6). Following the ini- 
tial fall, there was no significant further de- 
crease over the ensuing 3.5 hr; in addition, 
there were no significant intergroup differ- 
ences. 
DISCUSSION 
The hemodynamic changes which accom- 
pany acute pancreatitis have long been of in- 
terest. Historically, systemic changes resulting 
from acute pancreatitis were the primary fo- 
cus of attention. Local changes occurring in 
pancreatic hemodynamics have elicited in- 
creasing attention, as it has become more ap- 
parent that the prcgression of pancreatitis from 
a benign reversible condition to one of pan- 
creatic necrosis may be mediated by local vas- 
cular changes. That these vascular factors may 
be of significance has been shown experimen- 
tally in models where acute hemorrhagic pan- 
creatitis was induced by the injection of par- 
ticulate material into the pancreatic arterial 
circulation. Worsening pancreatitis appeared 
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FIG. 4. Total pancreatic blood flow and arteriovenous shunt flow following induction of pancreatitis. 
to develop in proportion to the extent of 
blockage of the pancreatic microcirculation 
[25]. It has also been shown that edematous 
pancreatitis can be transformed to hemor- 
rhagic pancreatitis by brief temporary occlu- 
sion of the arterial supply [27], or by occlu- 
sion of the pancreatic venous drainage [ 1, 31. 
Several investigators have demonstrated 
that pancreatic blood flow decreases after in- 
duction of acute pancreatitis. Early studies 
utilized the 86Rbdistribution method [ 15,231. 
A subsequent study utilizing venous outflow 
measurements confirmed findings of de- 
creased pancreatic blood flow in acute exper- 
imental pancreatitis [26]. Recently, using 
electromagnetic flow monitoring, the finding 
was further supported [8, 201. It is also of 
some interest that investigators have dem- 
onstrated that pancreatic blood flow decreases 
out of proportion to observed decreases in 
cardiac output following experimental pan- 
creatitis [8, 151. 
It has been suggested that the decreased 
pancreatic blood flow observed in acute pan- 
creatitis is due to a primary alteration in pan- 
creatic microcirculatory dynamics. Another 
alternative is that decreases in pancreatic blood 
flow may be secondary to decreased systemic 
5ow (cardiac output) and simply re5ect 
changes seen elsewhere in the body. We have 
previously demonstrated a decrease in pan- 
creatic blood 5ow 3 hr after induction of acute 
pancreatitis, despite administration of intra- 
venous 5uids at a rate sufficient to maintain 
cardiac index and CVP, no similar changes 
in pancreatic blood 5ow were seen in animals 
without acute pancreatitis [20]. These find- 
ings were confirmed in this study where, in 
spite of efforts to keep systemic changes to a 
minimum, significant decreases in pancreatic 
blood 5ow were seen in both groups of dogs 
(Figs. 4, 5). The observed decreases in the ra- 
tio of pancreatic 5ow to cardiac output (Fig. 
5), though not statistically significant, further 
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FIG. 5. Percent changes in pancreatic blood flow and in pancreatic flow as a fraction of cardiac output. 
Each dog served as its own control. 
suggest that the predominant contribution to Effective nutrient blood flow may also de- 
compromised pancreatic hemodynamics in crease as a result of increased AV shunting in 
acute pancreatitis is at the level of the pan- acute pancreatitis. Papp, using a bile-induced 


















i - DEX 
:I 
---- LR \ \ \ 
l pc .05 from baseline 
++ pc .Ol from baseline 
t p < .05 DEX vs LR 
01 ’ 1 I 1 I 
0 1 2 3 4 
Time after induction of pancreatitis 
[hours) 
FIG. 6. Pancreatic oxygen consumption following induction of pancreatitis. 
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capillary filling at three hr and an increase in 
both the size and number of AV shunts at 24 
hr [24]. Donaldson and Schenk showed a de- 
crease in pancreatic oxygen consumption as- 
sociated with acute pancreatitis and hypoth- 
esized an increase in AV shunting to explain 
the apparent paradox of a decreased oxygen 
consumption despite decreased total pan- 
creatic blood flow [9]. Although in the present 
study the percentage of total pancreatic blood 
flow passing through AV shunts increased fol- 
lowing the induction of acute pancreatitis, the 
actual flow rate through AV shunts remained 
remarkably constant at l-2 ml/min (Fig. 4). 
The decrease in pancreatic capillary flow 
closely paralleled changes in total pancreatic 
blood flow. 
Altered cellular metabolism may also be 
important in the progression of pancreatitis. 
Decreased blood flow accompanied by in- 
creased oxygen extraction has been demon- 
strated in hypovolemic and cardiogenic shock 
states [30]. Paradoxically, the decrease in total 
pancreatic blood Ilow is associated with a de- 
crease in pancreatic oxygen extraction in acute 
hemorrhagic pancreatitis [6, 9, 201. Our pres- 
ent data confirm that a fall in pancreatic ox- 
ygen consumption occurs after the induction 
of acute pancreatitis, with a sharp decrease 
(35 and 54% in LR and DEX groups, respec- 
tively) observed during the first 30 min, fol- 
lowed by a relative plateau at a decreased level 
(Fig. 6). The causes for this decrease in pan- 
creatic oxygen consumption are not apparent. 
The pattern of decreased oxygen consump- 
tion does not parallel the decline in pancreatic 
blood flow, and is not associated with an in- 
crease in arteriovenous shunt flow. Therefore, 
other possibilities must be entertained. A shift 
in the oxygen-hemoglobin affinity has been 
shown in acute pancreatitis [ 171, but a sig- 
nificant shift is unlikely in our study because 
of observed increases in systemic oxygen ex- 
traction (Fig. 3). An attractive- hypothesis is 
that the initial insult causes metabolic damage 
to the pancreatic cell, with subsequent in- 
ability to utilize oxygen normally. Similar lo- 
cal metabolic changes in oxygen consumption 
have been noted in septic shock [3 11. 
Low molecular weight dextran has been 
proposed as a therapeutic agent to prevent or 
reverse some of the microcirculatory and met- 
abolic changes in the acutely inflamed pan- 
creas. Initial trials of dextrans in acute ex- 
perimental pancreatitis used clinical dextran, 
similar in molecular weight to dextran 70, and 
hoped to utilize its volume-expanding effects 
[ 191. Subsequently, rheologic and antithrom- 
botic properties were described for LMW dex- 
tran which made it seem an ideal substance 
for use in pancreatitis. Gelin described de- 
creased sludging of blood in small lumen ves- 
sels, in low-flow states associated with inflam- 
matory processes, following infusion of LMW 
dextran [ 131. The antithrombotic effect of 
LMW dextran should decrease formation of 
the microthrombi which have been demon- 
strated in low-flow states [ 181. Both properties 
would theoretically help to improve pan- 
creatic microcirculatory flow in acute pan- 
creatitis. Experimentally, LMW dextran has 
been found to improve pancreatic blood flow 
in acute pancreatitis [6, 8, 151. Further sup- 
port for the use of LMW dextran comes from 
experimental studies in which decreased pan- 
creatic oxygen consumption resulting from 
acute pancreatitis is partially normalized by 
the administration of LMW dextran [6, 81. 
Improved pancreatic blood flow has been 
proposed as the mechanism of action of this 
agent [8]. 
To date, evidence that increasing pan- 
creatic blood flow will ameliorate the course 
of acute pancreatitis is all indirect. In one 
study, lysis of iatrogenically induced thrombi 
in the superior pancreaticoduodenal vein us- 
ing streptokinase resulted in markedly im- 
proved survival; presumably clot lysis re- 
stored normal pancreatic venous outflow [ 141. 
In another study, vasopressin administered to 
dogs with bile-trypsin-induced pancreatitis 
surprisingly increased survival [4]. It was sub- 
sequently shown that vasopressin causes in- 
creased pancreatic blood flow in experimental 
hemorrhagic pancreatitis [26]. Postganglionic 
sympathectomy has also been found to in- 
crease survival in dog models of acute hem- 
orrhagic pancreatitis presumably by increas- 
ing pancreatic blood flow [ 161. In the first 
published trial of LMW dextran in acute pan- 
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creatitis, Anderson and Lewis were unable to 
demonstrate any significant improvement in 
survival [2]. However, other investigators sub- 
sequently observed improved survival rates 
with LMW dextran [7, 321, even if the infu- 
sion was initiated as late as 12 hr after in- 
duction of pancreatitis [32]. Nevertheless, the 
data do not show directly that increases in 
pancreatic blood flow rather than other fac- 
tors led to the increased survival rates. 
In contrast to this body of evidence, our 
data do not support the use of LMW dextran 
in acute pancreatitis. Compared to infusion 
of lactated Ringer’s solution alone, adminis- 
tration of LMW dextran changed none of the 
measured parameters significantly, including 
blood pressure, CVP, cardiac index, pan- 
creatic blood flow, or pancreatic oxygen con- 
sumption. Trends were observed, but despite 
large numbers of animals in each group, no 
significant advantages resulting from the use 
of LMW dextran were observed. 
Why then are the results found with LMW 
dextran in our study different from those of 
other investigators? Several possibilities exist. 
First, the volume effects of LMW dextran may 
play a role. Plasma volume deficits of 35-45% 
have been measured at 6 hr in animals with 
untreated acute pancreatitis [ 191. When ad- 
ministered as a bolus, LMW dextran ( 10% 
solution) has been shown to increase plasma 
volume equal to the amount infused [ 121. In 
contrast, crystalloid infusion increases plasma 
volume much less than the volume admin- 
istered [ 121. Critical evaluation of all experi- 
mental trials of LMW dextran in acute pan- 
creatitis shows that in no case was an ade- 
quate volume of fluid administered to control 
animals. Our preliminary studies of canine 
acute pancreatitis showed that at least 6.5 ml/ 
kg/hr of crystalloid was required to maintain 
blood pressure and CVP. However, the max- 
imum fluid administered to controls in other 
published trials of LMW dextran was the 
equivalent of 2.0 ml/kg/hr of crystalloid or 
1.25 ml/kg/hr of albumin. In none of those 
studies can the effect of LMW dextran on 
pancreatic blood flow be separated from its 
systemic volume effects. Because of large sup- 
plemental fluid replacement, in our series the 
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volume effect of LMW dextran was mini- 
mized. 
A second consideration is that of LMW 
dextran dosage. There are no available dose- 
response data for the rheologic effects of LMW 
dextran. The dosage used has ranged from 0.2 
g/kg [ 1 l] to 1.5 g/kg [6], often administered 
as a bolus. The dose used in this study (0.15 
g/kg/hr as a continuous infusion) was similar 
to that used by Donaldson ef al. [8]. Although 
renal excretion of a bolus of LMW dextran is 
half complete at 4 hr [5], rapid excretion in- 
volves only the smaller molecules. The larger 
molecular weight fraction is excreted very 
slowly [ 121. Therefore, administration of 
LMW dextran by continuous infusion results 
in an initially low but progressively rising 
blood level. This is in contrast to the initially 
high but thereafter decreasing LMW dextran 
level associated with bolus infusion. The ef- 
fects of dosage and method of administration 
may be important in determining the efficacy 
of LMW dextran, but further studies will be 
required to clearly elucidate the influences of 
those variables. 
LMW dextran may affect a multitude of 
other factors. Many trials have utilized sur- 
vival as the end point, without attempting to 
control for systemic factors. The dramatic fall 
in arterial blood pressure seen by Donaldson 
et al. following the induction of acute pan- 
creatitis was reproducible and severe (25% re- 
duction) in all experimental animals [ 81. Shock 
leads to a host of additional systemic changes, 
as well as possible pancreatic changes. In the 
face of an increasing number of variables, the 
effect of LMW dextran on a single variable is 
more difficult to assess. 
Finally, the time factor may be important. 
What happens with the administration of 
LMW dextran beyond 4 hr from the induc- 
tion of acute pancreatitis cannot be deter- 
mined from our data. 
CONCLUSIONS 
1. Total pancreatic blood flow decreases 
significantly after induction of bile-trypsin-in- 
duced acute pancreatitis in the dog. The de- 
creases in nutrient capillary flow alone ac- 
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count for the overall flow reduction. There is 
no change in flow through AV shunts. 
2. Pancreatic oxygen consumption falls 
early in the course of acute pancreatitis. The 
observed decrease despite reduced total pan- 
creatic blood flow and unchanged AV shunt 
flow suggests that early metabolic damage to 
the cell may be responsible. 
3. Low molecular weight dextran admin- 
istered intravenously at a dose of 1.5 ml/kg/ 
hr produces no significant improvement in 
pancreatic microcirculatory dynamics or in 
oxygen consumption in early acute pancre- 
atitis. 
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